Interactive Session:
103. "Achy Breaky Heart": Challenging Cases in Cardiovascular Infections
Friday, October 5, 2018: 8:45 AM-10:00 AM
Room: W 2005-2024

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the use of molecular diagnostic tests in endocarditis
  • discuss the role of diagnostic imaging in endocarditis
  • evaluate the role of surgical management in patients with endocarditis

Target Audience: Academicians, Clinicians, Fellows, HIV clinicians, HIV specialists, Infectious diseases pediatricians, Infectious diseases physicians, Medical students and residents, Members-in-training, Microbiologists, Nurses, Pharmacists, Researchers, Scientists

Tracks: Trainee, Adult ID, Pediatric ID


Chair:  Adarsh Bhimraj, MD FIDSA, Cleveland Clinic

Interactive Moderators:  Vance G. Fowler Jr., MD, Duke University Medical Center and Nabin Shrestha, MD, MPH, FIDSA, FSHEA, Cleveland Clinic

Interactive Panelists:  M. Rizwan Sohail, MD, Mayo School of Graduate Medical Education , Laila Woc-Coburn, M.D., Baylor College of Medicine/ The National School of Tropical Medicine , Gosta Pettersson, MD, PhD, Cleveland Clinic and Dhruv Kazi, MD, MSc, MS, Zuckerberg San Francisco General Hospital

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-18-220-L01-P

Disclosures:

A. Bhimraj, None

V. G. Fowler Jr., Cerexa/Actavis/Allergan, Pfizer, Advanced Liquid Logics, NIH, MedImmune, Basilea Pharmaceutica, Karius, ContraFect, Regeneron Pharmaceuticals, and Genentech: Grant Investigator , Grant recipient . Achaogen, Astellas Pharma, Arsanis, Affinergy, AmpliPhi, Basilea Pharmaceutica, Bayer, Cerexa Inc., ContraFect, Cubist, Debiopharm, Durata Therapeutics, Grifols, Genentech, MedImmune, Merck, The Medicines Company, Pfizer, Novartis, NovaDigm Therapeutics: Consultant , Consulting fee . Theravance Biopharma, Inc., and Green Cross: Lecturer , Speaker honorarium . UpToDate: Author , Royalties .

M. R. Sohail, None

See more of: Interactive Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.